<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">73679</article-id><article-id pub-id-type="doi">10.7554/eLife.73679</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Evolutionary Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Parallel evolution of Pseudomonas aeruginosa phage resistance and virulence loss in response to phage treatment <italic>in vivo</italic> and <italic>in vitro</italic></article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-252565"><name><surname>Castledine</surname><given-names>Meaghan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5752-2641</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123238"><name><surname>Padfield</surname><given-names>Daniel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6799-9670</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-257419"><name><surname>Sierocinski</surname><given-names>Pawel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-257420"><name><surname>Soria Pascual</surname><given-names>Jesica</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-257429"><name><surname>Hughes</surname><given-names>Adam</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-257454"><name><surname>Mäkinen</surname><given-names>Lotta</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-257423"><name><surname>Friman</surname><given-names>Ville-Petri</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233862"><name><surname>Pirnay</surname><given-names>Jean-Paul</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-257424"><name><surname>Merabishvili</surname><given-names>Maya</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-257425"><name><surname>de Vos</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-84407"><name><surname>Buckling</surname><given-names>Angus</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">College of Life and Environmental Sciences</institution>, <institution>University of Exeter</institution>, <addr-line><named-content content-type="city">Penryn</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Department of Biology</institution>, <institution>University of York</institution>, <addr-line><named-content content-type="city">York</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Laboratory for Molecular and Cellular Technology</institution>, <institution>Queen Astrid Military Hospital</institution>, <addr-line><named-content content-type="city">Brussels</named-content></addr-line>, <country>Belgium</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1188"><name><surname>Storz</surname><given-names>Gisela</given-names></name><role>Reviewing editor</role><aff><institution>National Institute of Child Health and Human Development</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>mcastledine96@gmail.com</email> (MC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>02</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e73679</elocation-id><history><date date-type="received"><day>07</day><month>09</month><year>2021</year></date><date date-type="accepted"><day>20</day><month>02</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Castledine et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Castledine et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-73679-v1.pdf"/><abstract><p>With rising antibiotic resistance, there has been increasing interest in treating pathogenic bacteria with bacteriophages (phage therapy). One limitation of phage therapy is the ease at which bacteria can evolve resistance. Negative effects of resistance may be mitigated when resistance results in reduced bacterial growth and virulence, or when phage coevolve to overcome resistance. Resistance evolution and its consequences are contingent on the bacteria-phage combination and their environmental context, making therapeutic outcomes hard to predict. One solution might be to conduct '<italic>in vitro</italic> evolutionary simulations' using bacteria-phage combinations from the therapeutic context. Overall, our aim was to investigate parallels between <italic>in vitro</italic> experiments and <italic>in vivo</italic> dynamics in a human participant. Evolutionary dynamics were similar, with high levels of resistance evolving quickly with limited evidence of phage evolution. Resistant bacteria - evolved <italic>in vitro</italic> and <italic>in vivo</italic> - had lower virulence. <italic>In vivo</italic>, this was linked to lower growth rates of resistant isolates, whereas <italic>in vitro</italic> phage resistant isolates evolved greater biofilm production. Population sequencing suggests resistance resulted from selection on <italic>de novo</italic> mutations rather than sorting of existing variants. These results highlight the speed at which phage resistance can evolve <italic>in vivo</italic>, and how <italic>in vitro</italic> experiments may give useful insights for clinical evolutionary outcomes.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/N0137941/1</award-id><principal-award-recipient><name><surname>Castledine</surname><given-names>Meaghan</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000288</institution-id><institution>Royal Society</institution></institution-wrap></funding-source><award-id>CH160068</award-id><principal-award-recipient><name><surname>Buckling</surname><given-names>Angus</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000270</institution-id><institution>Natural Environment Research Council</institution></institution-wrap></funding-source><award-id>NE/S000771/1</award-id><principal-award-recipient><name><surname>Buckling</surname><given-names>Angus</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Royal Higher Institute for Defence</institution></institution-wrap></funding-source><award-id>HFM 19-12</award-id><principal-award-recipient><name><surname>Merabishvili</surname><given-names>Maya</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000268</institution-id><institution>Biotechnology and Biological Sciences Research Council</institution></institution-wrap></funding-source><award-id>BB/T014342/1</award-id><principal-award-recipient><name><surname>Friman</surname><given-names>Ville-Petri</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The decolonisation study protocol was approved by the Leading Ethics Committee of the &quot;Université Catholique de Louvain&quot; (Avis N{degree sign}: B-403201111110). The study was performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and as revised in 2013. The patients gave informed consent and their anonymity was preserved.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data and R script files can be found at the following GitHub repository. This repository outlines how the files may be used for analysis and Figure production. A full description of data file meanings and annotated R scripts is provided.https://github.com/mcastledine96/Parallel_evolution_phage_resistance_virulence_trade-offs_invivo_invitroRaw sequencing files have been archived on the European Nucleotide Archive with the project accession number PRJEB47945https://www.ebi.ac.uk/ena/browser/view/PRJEB47945?show=reads</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Castledine M</collab></person-group><year iso-8601-date="2021">2021</year><source>Parallel evolution of phage resistance - virulence trade - offs during in vitro and nasal Pseudomonas aeruginosa phage treatment.</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ena/browser/view/PRJEB47945?show=reads">https://www.ebi.ac.uk/ena/browser/view/PRJEB47945?show=reads</ext-link><comment>ENA, PRJEB47945</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Castledine M</collab></person-group><year iso-8601-date="2021">2021</year><source>Parallel evolution of Pseudomonas aeruginosa phage resistance and virulence loss in response to phage treatment in vivo and in vitro</source><ext-link ext-link-type="uri" xlink:href="https://github.com/mcastledine96/Parallel_evolution_phage_resistance_virulence_trade-offs_invivo_invitro">https://github.com/mcastledine96/Parallel_evolution_phage_resistance_virulence_trade-offs_invivo_invitro</ext-link><comment>GitHub</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-73679-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>